Results 111 to 120 of about 13,217 (287)
Combined Effects of Romosozumab and Zoledronate on the Development of Osteonecrosis of the Jaw
Oral Diseases, EarlyView.ABSTRACT Objective This study aimed to assess the occurrence of medication‐related osteonecrosis of the jaw (MRONJ) in mice following the sequential administration of romosozumab and zoledronate and to confirm their inhibitory effects on osteoclast differentiation in vitro.
Hae‐Seo Park +5 more
wiley +1 more source
Oral Health Screening Prior to Oncological Treatment—The Helsinki Protocol
Oral Diseases, EarlyView.ABSTRACT Objectives Oncological treatments can have adverse effects on oral health and cause long‐term complications such as osteonecrosis. This retrospective study investigated the oral health of head and neck cancer patients before radiotherapy and patients with multiple myeloma, breast, prostate, lung, and kidney cancers before antiresorptive ...
Jemina Järvinen +4 more
wiley +1 more source
Oral Diseases, EarlyView.ABSTRACT Objectives To determine whether pretreatment radiomics can predict medication‐related osteonecrosis of the jaw (MRONJ). Methods Patients with mandibular MRONJ at Hiroshima University Hospital (2009–2024) who underwent MDCT before initiating bone resorption inhibitors were retrospectively identified. Records from 2009 to 2020 were also reviewed
Masaru Konishi
wiley +1 more source
Early-Onset Bevacizumab-Associated Knee Osteonecrosis in a Young Adult With Astrocytoma
Annals of Internal Medicine: Clinical CasesWe describe a rare case of knee osteonecrosis in a 22-year-old man with astrocytoma and neurofibromatosis type 1 after short-term treatment with bevacizumab and corticosteroids. Magnetic resonance imaging (MRI) identified infarctions and osteonecrosis of
Chandra L. Kakarala +5 more
doaj +1 more source
Oral Surgery, EarlyView.ABSTRACT Objective This study aimed to investigate the self‐reported confidence levels of final year dental students at the University of Queensland, Australia, in oral surgery procedures and general medicine to locate gaps in knowledge and aid in improving the dental curriculum.
Hsin‐Chen Lee +4 more
wiley +1 more source
Actinomycosis and osteonecrosis of the jaw : every why hides a why
, 2021 Actinomycosis and osteonecrosis of the jaw : every why hides a ...
25TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CRANIO MAXILLO FACIAL SURGERY - EACMFS 2021 +3 more
core
Knowledge of Iranian Dentists about Osteonecrosis of the Jaw due to the Use of Bisphosphonate Drugs
Pesquisa Brasileira em Odontopediatria e Clínica IntegradaObjective: To evaluate the knowledge of Iranian dentists regarding bisphosphonate-related osteonecrosis of the jaw (BRONJ) etiology, risk assessment, and clinical management, aiming to identify gaps in knowledge and inform targeted educational ...
Zahra Atai +4 more
doaj
Revista medica de Chile, 2021 Medication-related osteonecrosis of the jaw is a disease where there is necrotic bone exposed or that can be explored by means of a fistula in the maxillofacial region. It has been associated with the use Biphosphonates and denosumab for osteoporosis. Although its etiology is unclear, it may be related to a decrease in bone turnover produced by these ...
Camila, Foncea +7 more
openaire +1 more source
Photochemistry and Photobiology, EarlyView.This study evaluated the combined effects of antimicrobial photodynamic therapy (aPDT) and systemic resveratrol on bone repair around immediately placed implants in type 2 diabetic rats. Resveratrol improved glycemic control and body weight, while aPDT increased implant stability and bone mineralization.
Letícia Pitol‐Palin +8 more
wiley +1 more source
Bisphosphonates induced osteonecrosis of the jaw: a medical enigma?
, 2009 Bisphosphonates are used for the standard of care of patients with skeletal metastases and hypocalcemia of malignancy. Bisphosphonate-induced osteonecrosis (BION) is a serious complication.
Payne, Alan G.T. +2 more
core +1 more source